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Causal Relationship between the Loss
of RUNX3 Expression and Gastric Cancer
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region termed the Runt domain, which is required for or response to the mother. However, Runx3/ mice
died soon after birth. In the first day after birth, 75% ofdimerization with the  subunit and for recognition of
the cognate DNA binding sequence. There are three Runx3/ mice died, and none survived beyond 10 days.
Blood sugar levels in Runx3/ mice were very low andmammalian runt-related genes, RUNX1/AML1, RUNX2/
CBFA1, and RUNX3/PEBP2C/AML2. RUNX proteins therefore, knockout mice may have died by starvation.
We noted that the stomach wall of Runx3/ mice wasform complexes with Smad2 and Smad3 that transmit
TGF-/activin signals (Hanai et al., 1999). RUNX1 is re- thicker than that of wild-type (wt) animals. We thus com-
pared the gastric tissue structures by fixing the stom-quired for definitive hematopoiesis (Okuda et al., 1996).
It is the most frequent target of chromosome transloca- achs just after parturition before suckling commenced.
In the fundic area near the forestomach, the glandtion in leukemia and is responsible for about 30% of
human acute leukemia cases (Look, 1997). RUNX2 is was more elongated in the knockout mice than wt ani-
mals. Thus, the stomach mucosa of Runx3/ mice isessential for osteogenesis. Its haploinsufficiency causes
the human bone disease cleidocranial dysplasia (Lee et about twice as thick as that of wt mice (Figures 2A
and 2B), suggesting that disruption of Runx3 results inal., 1997; Mundlos et al., 1997).
In this communication, we show that the Runx3/ hyperplasia of the gastric mucosa. Immunohistochemi-
cal analysis of gastric epithelial proliferation by labelingmouse gastric mucosa exhibits hyperplasias due to the
stimulated proliferation and suppressed apoptosis in 18.5 dpc cells with BrdU showed that replicating cells
were localized at the gland base in both Runx3/ andthe cells. This line of evidence suggests that RUNX3 is
an attractive candidate as a tumor suppressor of gastric wt mice (Figures 2C and 2D) and that the labeling index
was significantly greater in the Runx3/ mouse than incancer and prompted us to investigate this possibility.
Indeed, we found that RUNX3 possesses a potent anti- wt mice in both the fundic and pyloric areas (p  0.05;
Figure 2E). This indicates that gastric epithelial prolifera-oncogenic activity and is frequently inactivated in gas-
tric cancers by hemizygous deletion and hypermethyla- tion was stimulated by the disruption of Runx3.
tion of its promoter region.
Runx3/ Gastric Epithelial Cells Are Less Sensitive
Results to the Growth-Inhibitory Effect of TGF-
The observations that disruption of Runx3 resulted in
Targeted Disruption of the Runx3 Locus in Mice increased proliferation and hyperplasia of gastric epi-
The strategy used to inactivate Runx3 in the mouse thelial cells, albeit not as severely as in TGF-1 null mice,
germline is described in Figure 1A. In order to follow suggest a link between TGF- and Runx3. To examine
the expression of Runx3, the lacZ reporter sequence whether hyperplasia and increased epithelial prolifera-
was inserted in frame into the Runx3 gene. The presence tion in Runx3/ gastric mucosa were due to impaired
of the null Runx3 alleles in the newborn mice was con- TGF- signaling pathway in the epithelial cells in a cell-
firmed by genomic Southern blot analysis (Figure 1B). autonomous fashion rather than the influence from sur-
rounding mesenchyme, the response of 18.5 dpc gastric
epithelial cells to TGF- was examined in primary cul-Runx3 Is Expressed in Gastrointestinal
ture.Epithelial Cells
The high purity of the gastric epithelial cell populationsIn the Runx3/ mouse fetus, which developed normally
without mesenchymal contamination was confirmedwithout apparent defects, -galactosidase (-gal) activ-
(Figure 2F). The epithelial cells from both wt andity could be detected histochemically. At 12.5 days post
Runx3/ mice proliferated rapidly in culture, and wtcoitus (dpc), -gal activity in the Runx3/ mouse was
epithelial cell growth was significantly inhibited by TGF-found in the cartilage in limbs and the nasal cavity, in
1 (Figure 2G). In contrast, Runx3/ epithelial celltrigeminal (Figure 1C) and dorsal root ganglia (Figure
growth was less severely inhibited (Figure 2H), and the1D). Strong -gal activity was found in gastrointestinal
difference between wt and Runx3/ cells was signifi-organs, including the stomach and the small and large
cant (p  0.05).intestines, from 14.5 dpc (Figure 1E) through to adult-
hood. In this study, we will focus our analysis on the
stomach, where Runx3 is strongly expressed. Gastric Epithelial Apoptosis Is Suppressed
In situ hybridization on the newborn stomach showed in Runx3/ Mice
that there was strong expression in epithelial cells of That Runx3/ gastric epithelial cells are less sensitive
the glandular stomach but only very weakly in the fore- to TGF- than wt cells suggests that gastric epithelial
stomach epithelia (Figure 1F). In the adult stomach, ex- apoptosis may also be altered in Runx3/ mice. We
pression was greater in chief and surface mucous cells thus examined epithelial apoptosis in the developing
than in the parietal cells (Figures 1H and 1I). Only weak gastrointestinal organs by the TdT-mediated dUTP-bio-
signals could be found in the stem cell zone where prolif- tin nick-end labeling (TUNEL) method.
erating cells could be labeled with 5-bromo-2-deoxyuri- In the newborn wt mouse, apoptotic cells were ob-
dine (BrdU) (Figures 1I and 1K). served in esophageal epithelial cells lining the luminal
surface (Figure 3A) and in gastric epithelial cells on the
surface of glandular structures (Figures 3C and 3E). InHyperplasia and Increased Epithelial Proliferation
in Runx3/ Gastric Mucosa the newborn Runx3/ mouse, apoptosis was found in
esophageal epithelial cells facing the lumen (Figure 3B),When Runx3/ mice were mated, about 20%–25% of
newborn mice were Runx3/. Newborn mice had no but no apoptotic cells were found in Runx3/ gastric
epithelium (Figures 3D and 3F). Consistent with this,genotype-dependent differences in body weight, size,
RUNX3 and Gastric Cancer
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Figure 1. Targeted Disruption of Runx3 and Expression of Runx3
(A) Genomic structure of Runx3, the structure of the targeting vector for homologous recombination, and the gene structure of the targeted
locus. Exons are indicated by boxes. A probe (shown on Runx3 locus) is used in genomic Southern blot analysis. Abbreviations: Runt, the
Runt domain; E, EcoR1; Xb, XbaI; S, SmaI; Neo, neo-resistant gene.
(B) Southern blot analysis of genomic DNAs of wt, Runx3/ (/), and Runx3/ (/) mice, detected by the probe shown in (A).
(C and D) Whole-mount -gal staining of a 12.5 dpc Runx3/ fetal mouse. In (C), positive reaction is depicted by an arrow, and arrowheads
indicate the trigeminal ganglion and the cartilage in the limb buds. In (D), a positive reaction in the bilateral dorsal root ganglia is shown.
Scale bars are equal to 1 mm.
(E) Whole-mount -gal staining of resected gastrointestinal tracts from 14.5 dpc fetal mice. Note that whole Runx3/ tissues apart from the
forestomach were positively stained. Scale bar is equal to 1 mm.
(F–I) Detection of Runx3 mRNA by in situ hybridization in the stomach (F) and the junction between the stomach and intestine (G) of a newborn
mouse and in the glandular stomach (H) of a 10-week-old mouse. In (F), the border between the glandular stomach (left) and forestomach
(right) is shown by arrowheads. In (G), the pylorus (right) and duodenum (left) can be distinguished, and the liver is indicated by an asterisk.
A rectangle in (H) is enlarged and shown in (I). Scale bars are equal to 100 m.
(J and K) Hematoxylin and eosin (HE) staining (J) and immunohistochemical detection of replicating cells (K) in sections similar to the region
shown in (I). Arrowheads in (K) indicate BrdU-incorporated nuclei.
caspase 3 was not activated in Runx3/ mouse gastric detached from the substratum to float in the culture
media, it was rare to find TUNEL-positive substratum-tissues (Figures 3G and 3H). These observations sug-
gest that Runx3 is essential in inducing apoptosis in attaching cells in control cultures (Figure 3J). When wt
cells were treated with TGF-1, however, many substra-gastric epithelial cells and that the epithelial hyperplasia
in the Runx3/ glandular stomach results, at least in tum-attaching cells were found to be TUNEL positive
(Figure 3N). In cultures of Runx3/ gastric epithelialpart, from reduced apoptosis of the epithelial cells.
We then investigated the effect of TGF- on gastric cells, in contrast, TUNEL-positive cells could not be
observed even if they were treated with TGF- (Figuresepithelial apoptosis in primary cell culture. In this experi-
ment, TGF-1 was added to the culture medium on 3L and 3P). We thus concluded that TGF-1 induces
apoptosis in gastric epithelial cells in primary cultureday 4 when spontaneous apoptosis could be observed.
Since apoptotic cells became round in shape and easily and that Runx3/ gastric epithelial cells are resistant
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Figure 2. The Growth Regulation of Gastric
Epithelial Cells by Runx3 and TGF-
(A and B) Light micrographs of the fundic area
in the stomach from mice fixed just after birth
before suckling, stained with periodic-acid
Schiff (PAS) reaction and hematoxylin. The
border of the glandular stomach (left) and the
forestomach (right) is indicated by arrow-
heads. Scale bars are equal to 100 m.
(C and D) Immunohistochemical detection of
replicating cells in the stomach from 18.5 dpc
fetal mice. Scale bars are equal to 100 m.
(E) Quantitative analysis of gastric epithelial
proliferation. The labeling index was calcu-
lated as a percentage of BrdU-labeled cells
in the total epithelial cell populations from
18.5 dpc fetal gastric tissues. Mean  SD of
five fetuses.
(F) Light micrographs of epithelial (epi) and
mesenchymal (mes) components from 18.5
dpc glandular stomach tissues fixed just after
separation by EDTA treatment and stained
with PAS and hematoxylin. Scale bars are
equal to 50 m.
(G) Growth of glandular stomach epithelial cells
in TGF-1 (3 ng/ml)-supplemented (black bars)
or in control (open bars) medium during pri-
mary culture. The number of cells in control
medium on day 3 was regarded as 100%.
Mean  SD of 4–6 determinations.
(H) Relative number of gastric epithelial cells on day 3 of culture in TGF-1-supplemented media. The cell number in the control medium is
regarded as 100%.
to this apoptosis-inducing action of TGF-. These ob- ization (FISH). Most cell lines exhibited aneuploidy, hav-
ing two, three, or more copies of chromosome 1 asservations prompted us to examine whether RUNX3 is
involved in human gastric cancer. revealed by a centromere-specific probe (green spots
in Figure 4A). The numbers of copies of chromosome 1
and RUNX3 were counted, and RUNX3/centromere spotHemizygous Deletion of RUNX3
First, we examined the integrity of the RUNX3 gene in ratio was determined. The ratio was always 1 (2/2) in
normal peripheral lymphocytes, but was less than 1 in15 gastric cancer cell lines by fluorescent in situ hybrid-
Figure 3. Detection of Apoptotic Cells by
TUNEL
(A–H) Fluorescent micrographs of esopha-
geal (A and B) and pyloric (C–H) tissues from
newborn mice. (E) and (F) are higher magnifi-
cations of sections in (C) and (D), respectively.
TUNEL-positive nuclei (A–F) are stained in
green. Immunohistochemical detection of ac-
tive-caspase 3 (G and H). Scale bars in (A)–(D)
are equal to 500 m and in (E)–(H) are equal
to 100 m.
(I–P) Gastric epithelial cells from wt (I, J, M,
and N) and Runx3/ (K, L, O, and P) fetal
mice in primary culture, treated with TGF-1
(M–P) or vehicle (I–L) and double-stained with
TUNEL and with propidium iodide. The same
area is shown in two accompanying figures
to show the location of TUNEL-positive nuclei
(J, L, N, and P) among all the nuclei (I, K, M,
and O). Scale bars are equal to 100 m.
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into the lymph node or liver, and peritoneal dissemina-
tion according to the UICC classification (Sobin and
Wittekind, 1997). Of the 46 specimens examined, 14
cases (30%) showed a hemizygous deletion of RUNX3,
including 3 out of 22 stage I (14%), none out of 2 stage
II, 3 out of 14 stage III, and 8 out of 8 stage IV cases
(100%). The proportion of hemizygous deletions signifi-
cantly increased as the cancer progressed to more ad-
vanced stages (p  0.01 examined by Mann-Whitney U
test).
Frequent Loss of RUNX3 Expression
We then examined the expression of RUNX3 in gastric
cancer cell lines by the reverse transcriptase-polymer-
ase chain reaction (RT-PCR) and found that expression
of RUNX3 was undetectable in six cell lines (SNU1,
NUGC3, MKN28, MKN74, AGS, and KATOIII), including
those with hemizygous deletions of RUNX3 (Figure 5A).
The expression level was very low in MKN7 cells (Figure
5A). Southern blot analysis of the amplified DNA using
the RUNX3 probe verified the authenticity of the RT-
PCR products (Figure 5A). Hence, out of the 15 cell
lines tested, little or no expression of RUNX3 could be
detected in seven lines (47%). RUNX3 expression in
SNU16 cells was confirmed by Northern blotting, and
the level of expression was found to be functionally
saturated (see below). Therefore, SNU16 cells were con-
sidered to constitute a positive control for RUNX3 ex-
pression.
In situ hybridization analysis showed that RUNX3 ex-
pression was also greatly reduced in the clinical speci-
mens (Figure 6). Figure 6D shows normal gastric mu-
cosa, while Figure 6E shows cancer cells with irregularly
shaped atypical tubular structures lined by pleomorphic
cells and enlarged irregularly shaped vesicular nuclei.
RUNX3 expression can be clearly detected in normal
gastric epithelial cells (Figure 6G) but only weakly in the
cancer tissue (Figure 6H). Figure 6F shows a higher
magnification of noncancerous mucosa marked F in Fig-
Figure 4. Hemizygous Deletions of RUNX3 in Gastric Cancer Cells ure 6A. Interestingly, the left half of the tissue displays
(A) Bicolor FISH analysis of RUNX3 in gastric cancer cell lines using intestinal metaplasia, while the right half shows normal
a centromere-specific probe (green) and a RUNX3-specific probe gastric mucosa. It is significant to note that RUNX3 ex-
(red). Peripheral blood lymphocytes were used as a normal cell pression is greatly reduced in the metaplasia tissue
control.
compared with normal epithelial cells (Figure 6I). If intes-(B) Bicolor FISH analysis of RUNX3 from surgically resected primary
tinal metaplasia represents a precancerous state, thegastric cancer cells obtained from five tumors (i, ii, iii, iv, and vi) and
result would suggest that downregulation of RUNX3 oc-one liver metastasis (v).
curs at early stages of carcinogenic processes.
Of 22 stage I cases, 9 (41%) did not express RUNX3
significantly. In the stage II, III, and IV cases, 1 out of 2some cell lines. In SNU1 and NUGC3 cells, the ratio was
(50%), 11 out of 14 (79%), and 7 out of 8 (88%) exhibited2/4 in most cells (71% and 73% of total cell populations,
reduction of RUNX3 expression, respectively. With onlyrespectively), while it was 2/3 in 48% and 1/3 in 42% of
one exception, all specimens having hemizygous dele-the AGS cell population (Figure 4A). Out of the 15 cell
tions of RUNX3 failed to express RUNX3 at a detectablelines tested, these three cell lines were considered to
level (p  0.01). In summary, RUNX3 expression washave hemizygous deletions of RUNX3.
reduced in 40% of early-stage carcinomas, and this levelNext, we looked for hemizygous deletions of RUNX3
increased to nearly 90% with the advancement of theby FISH in 46 surgically resected primary cancer speci-
cancer stage (p  0.05 examined by Mann-Whitney Umens. Six representative FISH analyses are shown in
test). On average, 60% of the clinical specimens showedFigure 4B. Tumor cells from these primary cancers also
reduced or no expression of RUNX3 in the cancer tissuedisplayed aneuploidy, and the RUNX3/centromere ratio
compared to the surrounding normal mucosa.was less than 1 in all cases (Figure 4B). A biallelic dele-
tion of RUNX3 was observed in some of the metastatic
tumor cells (Figure 4B, v). Progression of gastric cancer DNA Methylation of the Exon 1 Region of RUNX3
In cancer cells, the pattern of DNA methylation is oftenhas been classified into four stages, from I through IV,
depending on the depth of tumor invasion, metastasis altered. Growing evidence suggests that aberrant DNA
Cell
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Figure 5. Frequent Reduction of RUNX3 Expression in Gastric Cancer Cell Lines
(A) RT-PCR analysis of RUNX3 expression patterns in gastric cancer cell lines. Gels: RT-PCR reaction with the primer pairs Ps-N and Ps-C,
which cover the regions [Ps-NA and Ps-NB] and [Ps-CA and Ps-CB], respectively. The identity of the RT-PCR products obtained using the
Ps-C primer pair was confirmed by Southern blotting (Ps-C ST) using the RUNX3-specific probe. The same first-strand cDNA preparations
were subjected to RT-PCR amplification for PEBP2 and -actin. Bottom: Schematic diagram of RUNX3 cDNA in which the relative positions
of the PCR primers are shown. The Runt domain is indicated by a hatched box (Runt).
(B) Methylation status of the C residues between 218 and 69 relative to the translation initiation site of the RUNX3 exon 1 region. (i) The
nucleotide sequences of the products of methylation-specific PCR of the DNA samples from the gastric cancer cell lines together with the
wt RUNX3 sequence at the top. The first three cell lines do not express RUNX3 (Exp), while the remaining three express it (Exp). The red
C indicates that it was resistant to bisulfite treatment due to methylation. The blue T indicates that it was converted from C by bisulfite
treatment, suggesting that the residue was not methylated. (ii) The nucleotide sequences of the products of methylation-specific PCR of the
DNA samples from primary gastric cancer which do not express RUNX3 (Can/Exp) (#2, #3, and #4) and normal gastric mucosa which express
RUNX3 (Nor/Exp) (#1, #5, and #6). Asterisk indicates that the C residue of #3 sample is not methylated at this position.
(C) Reactivation of RUNX3 expression. Cells were cultured for 3 days in the presence of AZA (300 nM) or TSA (1 M) or a mixture of both.
Semiquantitative RT-PCR (see Experimental Procedures) was performed using the Ps-N primer set shown in (A), and the products were
visualized by ethidium bromide staining (P) or Southern blotting (S) using RUNX3 cDNA as a probe. Untreated SNU16 cells that express
RUNX3 were used as a control.
methylation of CpG islands around promoter regions cell lines with methylation-sensitive and -insensitive en-
zymes. The results showed a good correlation betweencan have the same effect as mutations in the coding
regions on the inactivation of tumor-suppressor genes a low-level or lack of expression of RUNX3 and methyla-
tion in the vicinity of the RUNX3 promoter (data not(Baylin et al., 2001). Since the promoter region of RUNX3
contains a typical CpG island (GenBank accession num- shown). We then directly examined the state of DNA
methylation of six representative clones (three express-ber AL023096), we examined the methylation state of
this region by digesting genomic DNA isolated from 15 ing and three not expressing RUNX3) by methylation-
RUNX3 and Gastric Cancer
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Figure 6. In Situ Hybridization of RUNX3 mRNA in a Primary Gastric Cancer Specimen
(A–C) HE staining (A) and in situ hybridization using an antisense probe (B) and a sense probe (C). Cancer tissue faces the lumen (upper side).
Scale bars are equal to 5 mm.
(D–I) Enlargement of boxed regions marked (D)–(I) in (A) and (B). (D) and (G) show normal mucosa; (E) and (H) show cancer cells; (F) and (I)
show a gastric tissue composed of normal mucosa (right half) and intestinal metaplasia (left half). Scale bars are 200 m.
specific PCR. In three cell lines not expressing RUNX3 methylation of CpG islands is the cause of reduced gene
expression (Cameron et al., 1999). To confirm that down-(SNU1, MKN28, and MKN74), the C residues of the CpG
dinucleotide sequence in the RUNX3 exon 1 region were regulation of RUNX3 expression is due to DNA methyla-
tion, the NUGC3, MKN28, and MKN74 cell lines werecompletely methylated, whereas those in three cell lines
expressing RUNX3 (MKN1, RF1, and RF48) were entirely cultivated in the presence of AZA, TSA, or a combination
of both. As shown in Figure 5C, expression of RUNX3methylation free (Figure 5B, i).
Three primary cancer specimens and three normal was reactivated in all three cases to a level that was
comparable to that of the control cell line, SNU16, con-gastric mucosa specimens were also examined for the
state of DNA methylation. Cancer specimens (#2, #3, sistent with the notion that hypermethylation of the CpG
island of the RUNX3 exon 1 region (Figure 5B) results#4) were all negative for RUNX3 expression, and their
C residues in the CpG dinucleotide within the region in the inactivation of RUNX3 expression.
were methylated (Figure 5B, ii). In contrast, normal tissue
samples (#1, #5, #6) were all positive for RUNX3 expres- Mutation in RUNX3
As in the case of hemizygous deletion, silencing by DNAsion (data not shown), and none of their C residues were
methylated. The specimens #1 and #2 were obtained methylation may have affected gene(s) other than RUNX3.
To establish RUNX3 as causally related to gastric carci-from the same patient. Therefore, the result reempha-
sizes our conclusion that gastric cancer cells do not nogenesis, we examined whether primary gastric can-
cers or cell lines derived from them bear mutationsexpress RUNX3 due to hypermethylation of the exon 1
region, but normal epithelial cells surrounding the can- within the RUNX3 coding region. By single-strand con-
formation polymorphism (SSCP) analysis, we screenedcer tissue express RUNX3 with methylation-free exon 1
region. 119 tumor tissues, including the 46 mentioned above.
Although mutations in RUNX3 turned out to be rare,The silencing of gene expression by hypermethylation
is due to recruitment of histone deacetylase to the meth- we found the C to T transition at C373 by which arginine
122 was converted to cysteine (R122C) was within theylated DNA (reviewed by Baylin et al., 2001). 5-aza-2-
deoxycytidine (AZA), an inhibitor of DNA methyltransfer- evolutionarily conserved Runt domain. Unfortunately,
matching normal tissue was not available in this casease, and trichostatin A (TSA), an inhibitor of histone
deacetylase, reactivate gene expression when hyper- and therefore, it was not possible to tell whether the
Cell
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Figure 7. Inhibition of Tumorigenesis and In Vitro Cell Growth by RUNX3
(A) Tumorigenicity of MKN28 cells containing vector only (control), those expressing RUNX3 clone 1 (RUNX3-1) or clone 2 (RUNX3-2), and
those expressing RUNX3 (R122C) clone 1 (R122C-1) or clone 2 (R122C-2) were examined in nude mice. Cells were suspended in 0.85%
phosphate-buffered saline (5 	 107 cells/ml), and 0.3 ml of cell suspension was injected subcutaneously.
(B) Tumors obtained at the end of the experiment shown in (A). Two mice injected with RUNX3-1 did not bear detectable tumors.
(C) Northern blot analysis of RNA extracted from cells described in (A) and SNU16. RUNX3 cDNA was used as a probe.
(D) Growth curves of the cells in the monolayer culture.
(E) Growth curves of SNU16 cells (control) or SNU16 cells exogenously expressing RUNX3 (RUNX3). Inset shows the levels of expression of
endogenous (endo) and exogenous (exo) RUNX3.
(F) Growth curves of the cell lines in the monolayer culture.
(G) Tumor formation of WT-1, WT-2, /1, and /2 in nude mice 60 days after inoculation. Cells (1 	 107 ) of each cell line were inoculated
into five (wt) or seven (/) mice. The number of mice bearing tumors is indicated above the number of mice used for the experiment.
change we observed was a single-nucleotide polymor- derivatives obtained at the end of the experiment are
shown in Figure 7B. It was interesting to note that, notphism or a true mutation. Nevertheless, it is important
to note that arginine at position 122 is conserved in both only in vivo but also in vitro, RUNX3-expressing MKN28
cells grew more slowly than the parental cells, whilenematodes and humans. Furthermore, the equivalent
residue in RUNX2 has been shown to be mutated to RUNX3(R122C)-expressing MKN28 cells grew faster
than RUNX3-expressing cells (Figure 7D). The expres-glutamine in cleidocranial dysplasia (Zhou et al., 1999),
suggesting that the mutation impairs an important func- sion level of exogenously introduced RUNX3 was higher
than that of endogenous RUNX3 (Figure 7C). However,tion of RUNX proteins. We examined whether the muta-
tion affects the tumor-suppressive activity of RUNX3. it is unlikely that the tumor-suppressive effect displayed
by exogenous RUNX3 is due to a nonspecific toxic effect
induced by overexpression, since RUNX3(R122C), whichTumorigenesis Assay
The possible activity of RUNX3 as a tumor suppressor differs from RUNX3 by only one amino acid out of 415
and displays a similar level expression, did not show anywas examined by a tumorigenesis assay in nude mice.
MKN28 cells do not express RUNX3 (Figure 5A) and toxic effects. Furthermore, overexpression of RUNX3 in
the gastric cancer cell line SNU16, which does not haveformed rapidly growing tumors. Tumor growth was
greatly reduced when exogenous RUNX3 was stably a deletion in the RUNX3 locus and normally expresses
RUNX3, did not affect significantly the growth of theexpressed in the cells, suggesting that RUNX3 has anti-
oncogenic activity. On the other hand, the R122C muta- cells (Figure 7E). The result suggests that RUNX3 is a
negative cell growth regulator both in vivo and in vitrotion abolished the tumor-suppressor activity of RUNX3.
Two independent RUNX3(R122C)-expressing MKN28 and is consistent with the observation made with RUNX3
null gastric epithelial cells.cell lines grew faster than the parental cells (Figures 7A
and 7C). The tumors induced by MKN28 cells and their If RUNX3 is a tumor suppressor involved in gastric
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carcinogenesis, Runx3/ mice would be expected to In order to understand the antioncogenic activity of
RUNX3 in gastric cancer, it is worth considering the roleacquire gastric cancer. As we mentioned earlier, how-
ever, Runx3/ mice die soon after birth and therefore, of RUNX1 in leukemogenesis. Sporadic and hereditary
loss-of-function heterozygous mutations of RUNX1we are unable to see any tumor growth. To overcome
this problem, we obtained cell lines from epithelial cells have been described (Osato et al., 1999; Song et al.,
1999). Individuals who inherit heterozygous RUNX1 mu-of the glandular stomach of Runx3/p53/ as well as
Runx3/p53/ mice. The reason for using the p53 null tation develop acute myeloid leukemia (AML) at very
high frequency. Furthermore, biallelic loss of RUNX1 ismice was to enhance the chance of generating cell lines.
As shown in Figure 7F, cell lines obtained from Runx3/ associated with a subtype of AML classified as FAB M0,
suggesting that a complete loss of RUNX1 causes amice grew faster on monolayer cultures than those from
wt mice. More importantly, Runx3/ cells induced tu- least-differentiated subtype of AML (Osato et al., 1999).
A much larger percentage of AML cases are associatedmors (adenocarcinoma) in nude mice, whereas Runx3/
cells did not (Figure 7G). with the generation of leukemogenic chimeric proteins
involving RUNX1 and PEBP2/CBF. In these cases,Taken together, these results strongly suggest that
RUNX3 is a tumor-suppressor gene causally involved ample evidence shows that the chimeric proteins almost
always effectively inhibit the function of RUNX1 (Cleary,in gastric carcinogenesis.
1999), strongly suggesting that the loss of RUNX1 func-
tion is related to leukemogenicity. It is believed thatDiscussion
RUNX1 is essential for granulocytic differentiation and
that loss of RUNX1 function deprives myeloid progenitorWe demonstrated that Runx3, the third runt-related
cells of the capacity to differentiate but without harminggene, is expressed in the glandular stomach epithelial
their capacity for proliferation (Ito, 1999). This status ofcells, and Runx3 null gastric mucosa develops hyperpla-
myeloid progenitor cells is considered to be the basis forsias due to promotion of proliferation and suppression
the development of full-blown leukemia, which developsof apoptosis in epithelial cells. Stimulated by these ob-
after the accumulation of other multiple genetic alter-servations, we found silencing of RUNX3 in about 60%
ations. These observations suggest that RUNX1 is aof gastric cancer specimens examined. The level in-
tumor suppressor for AML. As in the case of RUNX1, losscreased from 40% at early stages of cancer to almost
of RUNX3 function may block differentiation pathways in90% as the cancer stage progressed. About one-third
stomach epithelium.of the cases at the earlier stages showed hemizygous
It is intriguing to note that RUNX3 was found to be adeletion of RUNX3, the incidence of which also in-
negative growth regulator of gastric epithelial cells bothcreased as the cancer stage advanced. Although rare,
from the Runx3 knockout studies and from studies onwe found one mutation, RUNX3(R122C), within the evo-
gastric cancer. It is already known that RUNX1 andlutionarily conserved Runt domain, pinpointing the im-
RUNX2 are involved in cell fate determination, that is,portance of RUNX3 as the gene inactivated by hemizy-
they are regulators of cell differentiation. It is of greatgous deletions and by silencing due to DNA methylation.
interest to study the molecular mechanisms of regula-Furthermore, RUNX3 displayed a tumor-suppressor ef-
fect in a tumorigenesis assay, and the RUNX3(R122C) tion of cell growth and differentiation mediated by
RUNX3.mutation completely inactivated this effect. Finally, cell
lines isolated from Runx3/p53/ mouse glandular The runt domain gene of Caenorhabditis elegans,
known as run, is expressed in seam cells and intestinalstomach epithelium were tumorigenic in nude mice,
whereas equivalent cell lines from Runx3/p53/ were cells. The seam cells, also known as lateral hypodermal
cells, correspond to blast cells, which provide hypoder-not. These results strongly suggest that RUNX3 is a
tumor suppressor whose inactivation is involved in gas- mal nuclei and postdeirid neuroblasts; double-strand
RNA interference that targeted the gene resulted in mal-tric carcinogenesis. It is also important to note that the
phenotype of Runx3/ mice was a subset of that de- formations of the hypodermis and intestine (Nam et al.,
2002). This suggests that not only are Runt domainscribed for TGF-1/ mice, suggesting that Runx3 is
an in vivo target of TGF- signaling pathway demon- genes involved in the development of the functional gut,
they also appear to be an evolutionarily conserved andstrated by animal experiments.
The human RUNX3 gene is located on the short arm important growth regulator of the gut. The gut is one of
the most primitive organs in animals. That Runx3, of theof human chromosome 1 at 1p36. The minimal deleted
region in chromosome 1 from the gastric cancer cells three Runx genes present in mammals, appears to be
the mediator of this task fits the picture in evolutionaryis mapped between the genomic markers D1S119 and
D1S246 (Ezaki et al., 1996). This region covers about 45 terms, as comparison of the genomic structure of the
Runx family genes suggests that Runx3 is the most prim-megabase pairs and contains about 200 genes, includ-
ing RUNX3, but no known tumor suppressors. itive of the three, and that the other two genes may have
diverged from it. That is, Runx3 is far smaller (about 70Recently, it has been recognized that hypermethyla-
tion of the CpG island of the promoter region silences kb) than the other Runx genes (more than 500 kb), and
it lacks an exon present in Runx1 and Runx2 that issome genes as effectively as inactivation of the gene
by mutations or deletions. These genes include RB, the important for interacting with proteins such as Ets-1
(Bae et al., 1995).von Hippel-Lindau gene, CDKN2A (p16INK4A), CDKN2B
(p15INK4B), E cadherin (E-cad), hMLH1, APC (reviewed by RUNX3 was found to be silenced frequently in gastric
cancer by hypermethylation of CpG islands in the exonJones and Laird, 1999), and the caspase 8 gene (Teitz
et al., 2000). RUNX3 appears to be a new addition to 1 region. Reactivation of the genes silenced by DNA
methylation by histone deacetylase inhibitors has beenthe list.
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growth inhibition was highest. The results were analyzed statisticallydescribed (Cameron et al., 1999). We have shown here
by the Mann-Whitney test and significance was set at p  0.05.that RUNX3 was indeed reactivated by the combination
For the study of TGF-1-induced apoptosis of glandular stomachof AZA and TSA. In this study, we have also shown that,
epithelial cells, cells were cultured on Lab-Tek Chamber Glass Slides
although on average 30% of the cases of gastric cancer (Nalge Nunc, 177380) precoated with dried collagen substrata. Glan-
show hemizygous deletion of RUNX3, mutations and dular stomach epithelial cells from each fetus were inoculated into
wells and cultured as above. TGF-1 (3 ng/ml) was added on daysmall deletions are very rare in the remaining allele or
4, and after 12 hr, cells were fixed with 4% paraformaldehyde forin either allele when both are silenced by hypermethyla-
TUNEL analysis.tion. Therefore, in most cases, reactivation of RUNX3
Gastric cancer cell lines (SNU1, SNU5, SNU16, SNU719, NUGC3,means reactivation of the gene without any mutations.
MKN1, MKN7, MKN28, MKN45, MKN74, KATOIII, and AZ521) were
Furthermore, exogenous expression of RUNX3 in a cell maintained in RPMI-1640 medium supplemented with 10% fetal
line with a silenced RUNX3 gene dramatically inhibited bovine serum. RF1 and RF48 cells, and AGS cells were cultured in
Leibovitz’s L-15 and in F-12 medium supplemented with 10% fetalthe tumor growth in nude mice. Together, these observa-
bovine serum, respectively.tions offer high hope that tumor growth in gastric cancer
Runx3/p53/ mice were mated to obtain Runx3/p53/ fe-may potentially be controlled by inducing the expression
tuses. Gastric epithelial cells were obtained from 16.5 dpc fetusesof silenced RUNX3 using reagents such as histone de-
and cultured as above on collagen gels. Rapidly growing cells were
acetylase inhibitors. subcultured on plastic and the cell lines, WT-1 and WT-2, were estab-
lished from Runx3/p53/ mice while /1 and /2 were ob-
Experimental Procedures tained from Runx3/p53/ mice.
Targeted Disruption of the Runx3 Locus in Mice
Detection of Apoptotic Cells
A phage DNA clone containing exon 3 of the Runx3 gene was iso-
Apoptotic cells were detected by the TUNEL method with a MEB-
lated from a 129/SvJ mouse genomic library (Stratagene). The phage
STAIN Apoptosis Kit Direct (MBL, 8445, Japan). Some cells were
clone was used to generate a gene-targeting vector by introducing
double-stained by TUNEL and propidium iodide to locate the nuclei.
the LacZ gene into the SmaI site (12th codon in-frame) of exon 3.
E14 mouse ES cells were cultured and transfected by electropora-
Gastric Cancer Specimenstion with the plasmid as described previously (Gomi et al., 1995).
Primary gastric cancer tissues (119) were surgically resected. OfCorrectly targeted ES cells were injected into C57BL/6 blastocysts,
them, 71 were obtained from the Department of Digestive Surgery,and the resulting chimeras were crossed with C57BL/6 females.
Kyoto Prefectural University of Medicine, and 48 were obtained from
the National Cancer Center Hospital, Tokyo. Of the total 119 clinical
-Gal Staining and Histological Analyses
specimens, 46 had undegraded RNA and therefore, were used forFor whole-mount histochemical detection of -gal activity, 12.5 dpc
in situ hybridization to examine the RUNX3 RNA expression levelfetuses and 14.5 dpc gastrointestinal tracts were fixed with 4%
and the integrity of the RUNX3 genomic DNA. The remainder wasparaformaldehyde and stained with X-gal cocktail as described
a good source of DNA, although RNA was partially degraded, and(Huang et al., 1998). For histological analysis, tissues were fixed
was used for screening for mutations.with 4% paraformaldehyde, embedded in paraffin, and sectioned
at 6 m. For immunohistochemical detection of active caspase 3,
Plasmids and Stable Transfectionrabbit antibodies against active caspase 3 (R&D systems, AF835, 1
RUNX3(R122C) was created by site-directed mutagenesis from theg/ml) were used and visualized by incubation with biotin-conju-
human RUNX3 cDNA (Bae et al., 1995). The wild-type and mutantgated second antibodies and then with streptavidin-FITC.
RUNX3 cDNAs (1775 bp and 1552 bp, respectively) were cloned into
pcDNA3.1/HisC (Invitrogen) to generate the expression constructs,In Situ Hybridization
pcDNA3.1-RUNX3 and pcDNA3.1-RUNX3(R122C), respectively.To detect Runx3 expression in the mouse stomach, in situ hybridiza-
Stable transfections were done with the Lipofectamine (GIBCO-tion was performed on 12 m frozen sections as described pre-
BRL).viously (Satake et al., 1995) using sense and antisense digoxigenin
(DIG)-labeled probes consisting of Runx3 nucleotides (AF155880)
FISH219 to 772 and 1023 to 1851. To detect RUNX3 expression in
To detect copy number changes in RUNX3, FISH was carried outhuman gastric cancer specimens, in situ hybridization on paraffin-
as described previously by Ishino et al. (1998). Two probes wereembedded sections was performed as described previously (Ya-
used: pUCl.77 (specific for the pericentromeric regions of chromo-mada et al., 1997) using sense and antisense DIG-labeled probes
some 1) and a RUNX3 BAC clone (RP11-84-D-1), which containsconsisting of RUNX3 nucleotides 550–848.
169 kb DNA including all of the exons of RUNX3. The PUC1.77 and
RUNX3 BAC probes were labeled with bio-16-dUTP and dig-11-Detection of Proliferating Cells
dUTP, respectively, by using a nick translation kit (Boehringer Mann-Proliferating cells were labeled with BrdU by using a BrdU Labeling
heim). In normal peripheral blood cells, two spots of the centromereand Detection Kit (Roche, 1299964). BrdU (30 mg/kg body weight)
signal were detected in 93.1% 3.1%, and two spots of the RUNX3was injected i.v. into 18.5 dpc pregnant mice, and 4 hr later the
signal were detected in 96.2%  2.5%. We defined a hemizygousfetal stomachs were fixed with 4% paraformaldehyde, embedded
deletion of RUNX3 as more than 20% of nuclei showing a RUNX3-in paraffin, and sectioned at 6 m.
to-centromere signal ratio of less than 1, as described by Ishino et
al. (1998).Cell Lines and Cell Culture
Glandular stomach epithelia could be separated from mesenchymes
using 30 mM EDTA-Hanks’ solution (a modified method of Matsu- RT-PCR
cDNAs were synthesized from total RNA obtained from various gas-bara et al., 1998). Glandular stomach epithelial cells from each fetus
were separately cultured in wells precoated with rat tail collagen gels tric cancer cells using an oligo-dT primer according to the manufac-
turer’s manual (GIBCO-BRL, Superscript kit). Using the cDNA as ain Ham’s F12 medium with growth factors as previously reported
(Fukamachi et al., 1994). TGF-1 (3 ng/ml) was added to the culture template, RUNX3 cDNA was amplified by the polymerase chain
reaction (PCR) with two pairs of PCR primers, Ps-N (Ps-NA, 5-CGCmedium at the start of the culture. Cell proliferation was determined
on days 1 to 6 by a modification of the tetrazolium assay using CACTTGATTCTGGAGGATTTGT-3; Ps-NB, 5-TGAAGTGGCTTGTG
GTGCTGAGTGA-3) and Ps-C (Ps-CA, 5-GAGTTTCACCCTGACCAMTT as a substrate as previously reported (Fukamachi, 1992). The
relationship between genotype and epithelial responsiveness to TCACTGTG-3; Ps-CB, 5-GCCCATCACTGGTCTTGAAGGTTGT-3).
To confirm the integrity of the prepared RNA, the same cDNAs wereTGF-1 was determined by comparing the cell numbers in TGF-1-
supplemented and control cultures on day 3 when TGF-1-induced subjected to PCR amplification of PEBP2/CBFB and -actin cDNA.
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When rough quantification was required, semiquantitative PCR was Kato, Y., Nakajima, T., Ariyama, T., Inazawa, J., et al. (1996). Deletion
mapping on chromosome 1p in well-differentiated gastric cancer.performed by removing two reaction cycles from the minimum satu-
rating reaction cycle. Br. J. Cancer 73, 424–428.
Fukamachi, H. (1992). Proliferation and differentiation of fetal rat
SSCP intestinal epithelial cells in primary serum-free culture. J. Cell Sci.
To detect RUNX3 mutations in clinical samples, SSCP analysis was 103, 511–519.
performed using the following primers: Exon1-F, 5-GGGAAGCCGCGC Fukamachi, H., Ichinose, M., Ishihama, S., Tsukada, S., Yasugi, S.,
CGTCTCC-3; Exon1-R, 5-CGAGGCTCTGGCTCCCGCAGC-3 (406 Shiokawa, K., Furihata, C., Yonezawa, S., and Miki, K. (1994). Fetal
bp); Exon2-F, 5-TAAGCTGTCCCCCTGCATCC-3; Exon2-R: 5-CAAT rat glandular stomach epithelial cells differentiate into surface mu-
GCTGAAATGGCGAGGC-3 (231 bp); Exon3-F, 5-GCCAACCGCCTGC cous cells which express cathepsin E in the absence of mesenchy-
CTCTATT-3; Exon3-R, 5-AGGGGGCTCGGTGGCACTT-3 (161 bp); mal cells in primary culture. Differentiation 56, 83–89.
Exon4-F, 5-TCTGGGGAAGCAACGGCTGA-3; Exon4-R, 5-CAGCCC
Fukushige, S., Matsubara, K., Yoshida, M., Sasaki, M., Suzuki, T.,CTCCCTCCGTG-3 (223 bp); Exon5-F,5-GAGCCAGGTCTAGAACT
Semba, K., Toyoshima, K., and Yamamoto, T. (1986). LocalizationAGG-3; and Exon5-R, 5-TTGAAGGTTGTTAGGGTCC-3 (721 bp). The
of a novel v-erbB-related gene, c-erbB-2, on human chromosomePCR products for exon 1 and exon 5 were digested with ApaI and
17 and its amplification in a gastric cancer cell line. Mol. Cell. Biol.SphI, respectively. The PCR products or restricted PCR products
6, 955–958.were applied to gels with or without glycerol, as described previously
Gomi, H., Yokoyama, T., Fujimoto, K., Ikeda, T., Katoh, A., Itoh, T.,(Ushijima et al., 1995).
and Itohara, S. (1995). Mice devoid of the glial fibrillary acidic protein
develop normally and are susceptible to scrapie prions. Neuron 14,Methylation-Specific PCR
29–41.Methylation-specific PCR was performed as reported previously (Her-
man et al., 1996). Briefly, genomic DNA denatured by NaOH was treated Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N.,
with sodium bisulfite and purified. The DNA was subjected to PCR Harawira, P., Taite, H., Scoular, R., Miller, A., and Reeve, A.E. (1998).
using following primers. The primer set used for untreated DNA: Rx3- E-cadherin germline mutations in familial gastric cancer. Nature 392,
5W (5-GAGGGGCGGCCGCACGCGGG-3), Rx3-3W (5-CGGCCGGC 402–405.
GCGGGCGCCTCC-3). The primer set used for detecting methylated Hanai, J., Chen, L.-F., Kanno, T., Ohtani-Fujita, N., Kim, W.-Y., Guo,
DNA: Rx3-5M (5-TTACGAGGGGCGGTCGTACGCGGG-3), Rx3-3M W.-H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M.-J., et al. (1999).
(5-AAAACGACCGACGCGAACGCCTCC-3). The primer set used for Interaction and functional cooperation of PEBP2/CBF with Smads.
detecting unmethylated DNA: Rx3-5U (5-TTATGAGGGGTGGTTGTAT Synergistic induction of the immunoglobulin germline Calpha pro-
GTGGG-3), Rx3-3U (5-AAAACAACCAACACAAACACCTCC-3). Meth- moter. J. Biol. Chem. 274, 31577–31582.
ylated nucleotides were verified by sequencing the PCR products.
Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D., and Baylin,
S.B. (1996). Methylation-specific PCR: a novel PCR assay for methyl-Acknowledgments
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